IL1-targeting therapies have been tested in animal and clinical trials for multiple cancer types [83,84,85], including non-small-cell lung cancer, breast cancer, colon cancer, and melanoma, but have not yet been tested for osteosarcoma. Here, IL1A is linked to cancer.